|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.200 GBX | +1.59% |
|
-1.54% | -54.93% |
| 29/05 | Poolbeg Pharma PLC - Shareholder/Analyst Call | |
| 27/05 | Poolbeg Pharma shares up after US FDA orphan drug designation | AN |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bearish |
| Resistance | 3.7 | 5.55 | 5.35 |
| Spread/Res. | -13.51% | -42.34% | -40.19% |
| Spread/Supp. | +20.75% | +33.33% | +30.61% |
| Support | 2.65 | 2.4 | 2.45 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- POLB Stock
- Charts Poolbeg Pharma PLC
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition